Drug hypersensitivity may manifest ranging from milder skin reactions (eg, maculopapular
exanthema and urticaria) to severe systemic reactions, such as anaphylaxis, drug reactions …

Drug‐induced skin disease or cutaneous adverse drug reactions (CADRs) are terms that
encompass the clinical manifestations of the skin, mucosae and adnexa induced by a drug …

Metamizole, also known as dipyrone, was introduced to the market nearly a century ago.
Due to its excellent analgesic, antipyretic, and spasmolytic properties combined with its …

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which can be
considered a late-onset allergic reaction, can cause serious long-term sequelae. SJS/TEN …

Severe cutaneous adverse drug reactions (SCARs) represent life-threatening medical
conditions and an appropriate causative diagnosis of these conditions is of the highest …

Severe cutaneous adverse reactions (SCARs), previously thought to be idiosyncratic or
unpredictable, are a deadly form of adverse drug reactions with skin manifestations. Current …

Drug hypersensitivity reactions (DHRs) are type B adverse drug reactions (ADRs)
traditionally defined as unpredictable, dose independent and not related to the drug …

Adverse drug reactions (ADRs) are common and important complications of drug therapy for
children. The risk for ADRs changes over childhood, as do the nature and types of ADRs …

An underappreciated problem in child health is the risk for adverse drug reactions (ADRs).
While there is an impression that children are at a lower risk than adults for ADRs, in fact a …

The KV7 potassium channel openers flupirtine and retigabine have been valuable options in
the therapy of pain and epilepsy. However, as a result of adverse reactions, both drugs are …